Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features.

Thumbnail Image

Files

JL - Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features.pdf (73.21 KB)

Embargo End Date

ICR Authors

Spain, Lavinia
 Larkin, James

Authors

Spain, L
Schmid, T
Gore, M
Larkin, J

Document Type

Journal Article

Date

2017-04-01

Date Accepted

2016-12-06

Abstract

Citation

European journal of cancer (Oxford, England : 1990), 2017, 75 pp. 243 - 244

DOI

10.1016/j.ejca.2016.12.040

URI

https://repository.icr.ac.uk/handle/internal/575

Rights

https://www.rioxx.net/licenses/all-rights-reserved

Source Title

Publisher

ELSEVIER SCI LTD

ISSN

0959-8049

eISSN

1879-0852

Collections

Clinical Studies

Research Team

Melanoma and Kidney Cancer

Notes